Open AccessSurvival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
Author(s) -
Sharanabasayyaswamy B. Hiremath,
Srinivas Ld
Publication year - 2013
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.106436
Subject(s) - terlipressin , medicine , hepatorenal syndrome , renal function , intensive care medicine , gastroenterology , cirrhosis
Terlipressin improves renal function in hepatorenal syndrome (HRS) is a known fact. However the reason for lack of its long-term survival benefits despite improvement in renal function remains unclear. The aim of this study was to analyze the survival benefits of terlipressin in HRS and to address the issue of non-responder state to terlipressin.